• August 8, 2022 | The Legal Intelligencer

    People in the News—August 8, 2022—Munley, Blank Rome, Armstrong Teasdale

    Munley Law has announced that partner Marion Munley was elected as the parliamentarian for the American Association for Justice (AAJ) at its annual convention in Seattle.

    3 minute read

  • August 1, 2022 | The Legal Intelligencer

    Stradley Ronon Duo Jumps to Armstrong Teasdale's Growing IP Platform

    Former Stradley IP co-chair Joe Rossi and partner Paul Legaard pointed to their new firm's name recognition and critical mass of patent professionals to explain the move.

    6 minute read

  • August 1, 2022 | National Law Journal

    Arnold & Porter Arrives in Amsterdam With Life Sciences Regs Offering

    With a small but growing life sciences sector, the Netherlands has played an increasingly important role in European pharmaceutical regulation ever since the European Medicines Agency moved from London to Amsterdam as a result of Brexit.

    5 minute read

  • Pfizer Inc. v. U.S. Dep't of Health & Human Servs.

    Publication Date: 2022-07-29
    Practice Area: Administrative Law
    Industry: Federal Government | Pharmaceuticals
    Court: U.S. Court of Appeals for the Second Circuit
    Judge: Circuit Judge Robert Sack
    Attorneys: For plaintiff: For Plaintiff-Appellant: Samantha Barrett Badlam, Ropes & Gray LLP, Washington, DC; Joan McPhee, Ropes & Gray LLP, New York, NY; Ilana H. Eisenstein, DLA Piper LLP, Philadelphia, PA, on the brief, Douglas Hallward-Driemeier, Ropes & Gray LLP, Washington, DC.
    for defendant: For Defendants-Appellees: Benjamin H. Torrance, on the brief, Rebecca S. Tinio, For Damian Williams, United States Attorney for the Southern District of New York, New York, NY.

    Case Number: 21-2764-cv

    Agency Properly Interpreted AKS When Rejecting Copay Aid Plan for 'Orphan' Heart Drug

  • July 26, 2022 | Law.com

    Opioid Manufacturer Teva Pharmaceuticals Reaches $4.25B Global Settlement

    Under the settlement, announced on Tuesday, Teva would provide $3.7 billion to states, local communities and Native American tribes, plus $1.2 billion worth of generic Narcan, a nasal spray used to treat opioid overdoses.

    4 minute read

  • July 26, 2022 | Texas Lawyer

    Opioid Manufacturer Teva Pharmaceuticals Reaches $4.25B Global Settlement

    Teva negotiated the deal with the plaintiffs executive committee in the opioid multidistrict litigation, along with a "working group" of attorneys general of 12 states, including Texas, California, New York and Pennsylvania.

    4 minute read

  • July 26, 2022 | The Recorder

    Opioid Manufacturer Teva Pharmaceuticals Reaches $4.25B Global Settlement

    Teva negotiated the deal with the plaintiffs executive committee in the opioid multidistrict litigation, along with a "working group" of attorneys general of 12 states, including California, New York, Pennsylvania and Texas.

    4 minute read

  • July 26, 2022 | New Jersey Law Journal

    Appeals Court Affirms $1.8M CEPA Award, $1.5M in Attorney Fees for Former Novartis Employee

    The New Jersey Appellate Division upheld a jury's verdict of $1.8 million and a judge's award of $1.5 million in attorney fees for a former Novartis employee fired after blowing the whistle on the purchase of a report from one of the company's distributors that she believed constituted a kickback.

    6 minute read

  • July 19, 2022 | Insurance Coverage Law Center

    Allianz Report Identifies the Top Causes of Claims Worldwide

    The company analyzed over 530,000 claims from 207 countries to identify the leading drivers of corporate losses.

    8 minute read

  • In re Seroquel XR Antitrust Litig.

    Publication Date: 2022-07-19
    Practice Area: Antitrust
    Industry: Pharmaceuticals | Retail | State and Local Government
    Court: U.S. District Court of Delaware
    Judge: District Judge Connolly
    Attorneys: For plaintiff: Carmella P. Keener, Cooch and Taylor, P.A., Wilmington, DE; Bruce E. Gerstein, Joseph Opper, Kimberly M. Hennings, Daniel Litvin, Garwin Gerstein & Fisher LLP, New York, NY; Peter R. Kohn, Joseph T. Lukens, Faruqi & Faruqi, LLP, Philadelphia, PA; David F. Sorensen, Caitlin G. Coslett, Berger Montague PC, Philadelphia, PA; Stuart E. Des Roches, Amanda Hass, Chris Letter, Dan Chiorean, Thomas J. Maas, Odom & Des Roches, LLC, New Orleans, LA; Susan C. Segura, Erin R. Leger, David C. Raphael, Jr., Smith Segura Raphael & Leger, LLP, Alexandria, LA; Russell A. Chorush, Heim Payne & Cho Rush, LLP, Houston, TX; Michael J. Barry, Grant & Eisenhofer P.A., Wilmington, DE; Robert G. Eisler, Deborah A. Elman, Chad B. Holtzman, Grant & Eisenhofer P.A., New York, NY; Sharon K. Robertson, Donna M. Evans, Matthew W. Ruan, Cohen Milstein Sellers & Toll PLLC, New York, NY; Michael J. Barry, Grant & Eisenhofer P.A., Wilmington, DE; Jayne A. Goldstein, Shepherd, Finkelman, Miller & Shah, LLP, Media, PA; J. Clayton Athey, Jason Wayne Rigby, Prickett, Jones & Elliott, P.A., Wilmington, DE; Barry L. Refsin, Alexander J. Egervary, Caitlin V. McHugh, Hangley Aronchick Segal Pudlin & Schiller, Philadelphia, PA; Monica L. Kiley, Eric L. Bloom, Hangley Aronchick Segal Pudlin & Schiller, Harrisburg, PA; J. Clayton Athey, Jason Wayne Rigby, Prickett, Jones & Elliott, P.A., Wilmington, DE; Scott E. Perwin, Lauren C. Ravkind, Anna T. Neil, Kenny Nachwalter, P.A., Miami, FL; Heidi M. Silton, Jessica N. Servais, Lockridge Grindal Nauen P.L.L.P., Minneapolis, MN; Peter Safirstein, Safirstein Metcalf LLP, New York, NY; Archana Tamoshunas, Taus, Cebulash & Landau, LLP, New York, NY; Lee Albert, Brian D. Brooks, Glancy, Prongay, & Myrray, New York, NY; Robert J. Kriner, Jr., Tiffany Joanne Cramer, Chimicles Schwartz Kriner & Donaldson-Smith LLP, Wilmington, DE; Dianne M. Nast, Joseph N. Roda, Michael D. Ford, NastLaw, Philadelphia, PA; Michael L. Roberts, Stephanie E. Smith, Roberts Law Firm US, PC, Little Rock, AR for plaintiffs.
    for defendant: Daniel M. Silver, Alexandrea M. Joyce, McCarter & English, LLP, Wilmington, DE; John E. Schmidtlein, Benjamin M. Greenblum, Colette T. Connor, Thomas S. Fletcher, Akhil K. Gola, Williams & Connolly, Washington, DC; Arthur G. Connolly, III, Alan Richard Silverstein, Connolly Gallagher LLP, Wilmington, DE; Christopher J. Marino, James E. Gallagher, Davis Malm & D'Agostine, P.C., Boston, MA; Jack B. Blumenfeld, Michael J. Flynn, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE; Stephen J. McIntyre, O'Melveny & Myers LLP, Los Angeles, CA; Brett J. Williamson, O'Melveny & Myers LLP, Newport Beach, CA; Ben Bradshaw, O'Melveny & Myers LLP, Washington, DC; John W. Shaw, Karen E. Keller, Nathan Roger Hoeschen, Shaw Keller LLP, Wilmington, DE; Thomas J. Lang, Christina E. Fahmy, Peter M. Boyle, Kilpatrick Townsend & Stockton LLP, Washington, DC for defendants.

    Case Number: D69888

    Antitrust claims arising from alleged reverse payment agreements were timely under the statute of limitations where each alleged supracompetitive sale constituted a discrete act that started the limitations period for that sale.